ERYTECH Pharma to partner with Teva for long term distribution agreement in Israel Post author:admERY Post published:May 17, 2011 Post category:Newsroom ERYTECH Pharma is pleased to announce it has signed an exclusive long term agreement with Teva for the registration, marketing, distribution and sale of Graspa®, the company‟s lead product, in Israel. You Might Also Like ERYTECH Pharma announces appointment of Marc Beer to the Supervisory Board February 17, 2011 ERYTECH provides financial update for Q2 2013 July 18, 2013 ERYTECH strengthens its intellectual property position in the US April 21, 2015